The aftermath of amiodarone therapy: Hyperammonemia and encephalopathy

T Waguespack, BT Cutshall, C Brooks - The Nurse Practitioner, 2022 - journals.lww.com
Amiodarone is a Vaughan-Williams class III antiarrhythmic drug that blocks potassium
channels resulting in lengthened cardiac action potential. 1 It has a prominent place in …

[引用][C] The aftermath of amiodarone therapy: Hyperammonemia and encephalopathy

T Waguespack, BT Cutshall… - The Nurse …, 2022 - pubmed.ncbi.nlm.nih.gov

The aftermath of amiodarone therapy: Hyperammonemia and encephalopathy

T Waguespack, BT Cutshall, C Brooks - The Nurse Practitioner, 2022 - journals.lww.com
Amiodarone is a Vaughan-Williams class III antiarrhythmic drug that blocks potassium
channels resulting in lengthened cardiac action potential. 1 It has a prominent place in …